SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001485003-18-000029
Filing Date
2018-03-23
Accepted
2018-03-23 16:45:17
Documents
1
Period of Report
2018-03-21
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K ebio-form8xknasdaqcomplian.htm 8-K 26852
  Complete submission text file 0001485003-18-000029.txt   27872
Mailing Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142
Business Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142 617-444-8550
Eleven Biotherapeutics, Inc. (Filer) CIK: 0001485003 (see all company filings)

IRS No.: 262025616 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36296 | Film No.: 18710662
SIC: 2834 Pharmaceutical Preparations